Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Local Measures to Prevent Diabetes in the Værnes Region. (VEND-RISK)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Norwegian University of Science and Technology
Information provided by (Responsible Party):
Norwegian University of Science and Technology Identifier:
First received: April 26, 2010
Last updated: November 8, 2016
Last verified: November 2016
This is a development project involving four different municipalities in Central Norway. The aim is to identify adults with overweight and with an increased risk of developing diabetes mellitus type 2, then to prevent the disease to develop by the means of a behaviour change programme. The programme is group based.

Condition Intervention
Diabetes Mellitus Type 2
Behavioral: Behavioural change programme

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: The VEND RISK-study. Preventing Diabetes Type 2 in Overweight Persons in the Værnes Region, Central-Norway.

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Diabetes mellitus type 2 [ Time Frame: Visit 1 (baseline) till Visit 9 (5 years) ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: April 2010
Estimated Study Completion Date: September 2017
Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: group programme
Group based behaviour change programme
Behavioral: Behavioural change programme
The programme consists of a introductory course, organised physical activity 2-3 times a week, meetings every 3rd month with lectures and theme nights, and organising self-help groups.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Living in Central Norway
  • Find Risc score > 15
  • Written, informed consent

Exclusion Criteria:

  • Severe mental disorder
  • Not being able to function in the group programme
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01135901

Contact: Monica T Devle

Vaernesregionen Recruiting
Meraker, Stjordal, Selbu, Tydal, Norway
Contact: Monica Devle   
Sponsors and Collaborators
Norwegian University of Science and Technology
Principal Investigator: Bård Kulseng, PhD Norwegian University of Technology and Science
  More Information

Responsible Party: Norwegian University of Science and Technology Identifier: NCT01135901     History of Changes
Other Study ID Numbers: 2010/696-2 
Study First Received: April 26, 2010
Last Updated: November 8, 2016
Health Authority: Norway: Ethics Committee

Keywords provided by Norwegian University of Science and Technology:
public health
community health services

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases processed this record on December 07, 2016